Healthcare • Biotechnology
EODHD (TTM) · as of Oct 13, 2026
End-of-day close from stored market data, not a live quote.
Sign in to see your position size
We’ll show you if MBRX is in your portfolio and how much it contributes.
Sign inLoading market dates
No upcoming ex-dividend date announced
No 8-K filings in the last 30 days.
1 top institutions tracked
Sentiment: bullish
Last trade: buy 70 days ago
Red flags: 3
18 filers reported a long position in MBRX for Q2 2026. 13-F holdings are filed up to 45 days after the quarter ends.
| Holder | Value | Shares | Shares vs Q1 2026 |
|---|---|---|---|
| GEODE CAPITAL MANAGEMENT, LLC | $131.8K | 47.3K | +46.2% |
| VANGUARD CAPITAL MANAGEMENT LLC | $117.8K | 42.2K | +204.4% |
| VANGUARD FIDUCIARY TRUST CO | $83.4K | 29.9K | +392.1% |
| XTX Topco Ltd | $64K | 22.9K | New |
| MORGAN STANLEY | $55.9K | 20K | +55,555.6% |
| Rockefeller Capital Management L.P. | $41.9K | 15K | +239.3% |
| Tower Research Capital LLC (TRC) | $9.8K | 3.5K | +91.5% |
| CITIGROUP INC | $7.5K | 2.7K | New |
| BARCLAYS PLC | $1.7K | 621 | New |
| BlackRock, Inc. | $1.4K | 491 | Unchanged |
Unlock detailed insider transactions, institutional holder changes, factor exposures, and personalized alerts. Start free with your own portfolio.